As described earlier, plasma levels of sPD-1 produced by tumor-specific T lymphocytes and sPD-L1 secreted by cancer cells have shown proportionality, suggesting a state of immune homeostasis that is favoring tumor cells (83–88). This evidence concerns the gene SPDL1 and cancer.